Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysisAndrea Boutros, Francesco Spagnolo, Marco Bruzzone et al.|European Journal of Cancer|2021Cited by 42
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysisAndrea Boutros, Francesco Spagnolo, Matteo Fraguglia et al.|European Journal of Cancer|2023Cited by 38
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic reviewFrancesco Spagnolo, Matteo Lambertini, Andrea Boutros et al.|European Journal of Clinical Investigation|2021Cited by 21
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureAndrea Boutros, Carlo Genova, Alberto Bottini et al.|ESMO Open|2023Cited by 21
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitorsAndrea Boutros, Enrica T. Tanda, Roberta Carosio et al.|Immuno-Oncology Technology|2023Cited by 9